CEL-SCI to put lab in Baltimore
CEL-SCI Corp. of Alexandria, Va., said yesterday that it has signed a 10-year lease for an 11,700-square-foot laboratory facility in Seton Hill Business Park.
The company, which tests treatments for cancer and other immune system diseases, said it is locating the facility in Baltimore because of the "good biotech infrastructure and attractive pricing" of city-owned space.
CEL-SCI expects to hire as many as 15 people, mostly professional research staff, in the next year as a result of the expansion.
It already has a small manufacturing facility at another company in the business park, Chesapeake Biological Laboratories Inc., to produce trial amounts of CEL-SCI's immune-boosting drug, Multikine.